Leveraging existing pediatric low-grade tumor specimens, clinical and imaging outcome data and artificial intelligence innovations to develop integrated biomarkers of response for children with low-grade glioma

This study will utilize artificial intelligence algorithms to predict underlying mutational status and outcomes for pediatric low grade glioma based on complex brain tumor MRI imaging features.